AI assistant
Rezolute, Inc. — Director's Dealing 2013
Feb 9, 2013
32362_dirs_2013-02-08_1bb0f9d3-d15f-49f2-84ad-2cd26b0c5b92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2013-01-31
Reporting Person: Huh Hoyoung (Director, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4000000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Purchase Common Stock | $0.75 | 2018-01-30 | Common Stock (2500000) | Direct |
Footnotes
F1: Konus Advisory Group, Inc. owns 4,000,000 shares of common stock of the Issuer. Dr. Huh and Mr. Nevan Elam are significant stockholders, managing members and members of the board of directors of Konus Advisory Group, Inc. Dr. Huh and Mr. Elam share voting and dispositive power of the shares of the Issuer's common stock held by Konus Advisory Group, Inc.
F2: Pursuant to the terms of the Reporting Person's option to purchase common stock (the "Common Stock Option"), 66.7% of the Common Stock Option vested on January 30, 2013 with the remaining 33.3% of the Common Stock Option to vest on May 31, 2013.